Incidence of and Risk Factors for Pulmonary Autograft Dilation After Ross Aortic Valve Replacement
Background The Ross procedure is an alternative to mechanical aortic valve replacement in the young. Early dilation of the pulmonary autograft root exposed to the systemic circulation has been reported. The aim of our study is to define the prevalence, risk factors, and consequences of autograft dil...
Gespeichert in:
Veröffentlicht in: | The Annals of thoracic surgery 2007-05, Vol.83 (5), p.1781-1789 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1789 |
---|---|
container_issue | 5 |
container_start_page | 1781 |
container_title | The Annals of thoracic surgery |
container_volume | 83 |
creator | Brown, John W., MD Ruzmetov, Mark, MD, PhD Rodefeld, Mark D., MD Mahomed, Yousuf, MD Turrentine, Mark W., MD |
description | Background The Ross procedure is an alternative to mechanical aortic valve replacement in the young. Early dilation of the pulmonary autograft root exposed to the systemic circulation has been reported. The aim of our study is to define the prevalence, risk factors, and consequences of autograft dilation. All consecutive adult and pediatric patients who underwent Ross procedure at our institution were retrospectively reviewed for autograft dilation. Methods Between 1993 and 2005, 170 patients (mean age, 24.9 ± 15.5 years; range, 1 month to 61 years) underwent Ross aortic valve replacement: 48% were younger than 19 years old. Eighty-seven additional procedures were performed in 58 patients (34%) at the time of the Ross procedure. End points of the study were freedom from autograft dilation ( z value more than +2.0), autograft dysfunction, autograft reoperation, and autograft replacement. Results There were 2 early and 1 late deaths during a mean follow-up of 5.1 ± 3.0 years (range, 1 month to 12 years). Actuarial survival at 10 years was 98%. Autograft dilation was identified in 31 patients (19%). Regurgitation (>2+) was identified in 12 patients (7%); all 12 had autograft dilation. At 10 years, freedom from autograft dilation was 82%, freedom from autograft dysfunction was 92%, freedom from reoperation on autograft was 92%, and freedom from autograft replacement was 96%. Cox proportional hazard analysis identified preoperative aortic annulus dilation ( z value more than +2.0; p = 0.004), younger age ( p = 0.05), time of surgery (before 2001; p = 0.002), and male sex ( p = 0.01) as predictive of autograft dilation, whereas preoperative ascending aorta diameter ( p = 0.01), male sex ( p = 0.03), and postoperative systemic hypertension ( p = 0.05) were predictive of autograft dysfunction. Conclusions Significant autograft dilation is not common after the Ross procedure. Significant autograft dysfunction affects a minority of patients, but it is more prevalent in those with autograft dilation. |
doi_str_mv | 10.1016/j.athoracsur.2006.12.066 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70432930</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0003497507000203</els_id><sourcerecordid>70432930</sourcerecordid><originalsourceid>FETCH-LOGICAL-c513t-d29138bcb8a944d395bca1e2e1dfa5e2fb9201aea1f87128788f6a7e50a9a2c23</originalsourceid><addsrcrecordid>eNqNkU1v1DAQhi1ERZfSv4B84pbgj3z5grQUCpUqFS3QqzVxxuBtEi-2U6n_Hke7UiVOnEbWvO-M53kJoZyVnPHm_b6E9NsHMHEJpWCsKbkoWdO8IBte16JoRK1ekg1jTBaVautz8jrGfX6K3H5FznlbNUIqtSH9zWzcgLNB6i2FeaA7Fx_oNZjkQ6TWB_ptGSc_Q3ii2yX5XwFsop_cCMn5mW5twkB3Pka69SE5Q-9hfES6w8MIBiec0xtyZmGMeHmqF-Tn9ecfV1-L27svN1fb28LUXKZiEIrLrjd9B6qqBqnq3gBHgXywUKOwvRKMAwK3XctF13adbaDFmoECYYS8IO-Ocw_B_1kwJj25aHAcYUa_RN2ySgolWRZ2R6EJ-d8BrT4EN-UDNWd65av3-pmvXvlqLnTmm61vTzuWfsLh2XgCmgUfjwLMlz46DDoat-IdXECT9ODd_2z58M8QM7rZGRgf8Anj3i9hziQ11zEb9Pc15zVm1q4RMyn_AjOKp0A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70432930</pqid></control><display><type>article</type><title>Incidence of and Risk Factors for Pulmonary Autograft Dilation After Ross Aortic Valve Replacement</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Brown, John W., MD ; Ruzmetov, Mark, MD, PhD ; Rodefeld, Mark D., MD ; Mahomed, Yousuf, MD ; Turrentine, Mark W., MD</creator><creatorcontrib>Brown, John W., MD ; Ruzmetov, Mark, MD, PhD ; Rodefeld, Mark D., MD ; Mahomed, Yousuf, MD ; Turrentine, Mark W., MD</creatorcontrib><description>Background The Ross procedure is an alternative to mechanical aortic valve replacement in the young. Early dilation of the pulmonary autograft root exposed to the systemic circulation has been reported. The aim of our study is to define the prevalence, risk factors, and consequences of autograft dilation. All consecutive adult and pediatric patients who underwent Ross procedure at our institution were retrospectively reviewed for autograft dilation. Methods Between 1993 and 2005, 170 patients (mean age, 24.9 ± 15.5 years; range, 1 month to 61 years) underwent Ross aortic valve replacement: 48% were younger than 19 years old. Eighty-seven additional procedures were performed in 58 patients (34%) at the time of the Ross procedure. End points of the study were freedom from autograft dilation ( z value more than +2.0), autograft dysfunction, autograft reoperation, and autograft replacement. Results There were 2 early and 1 late deaths during a mean follow-up of 5.1 ± 3.0 years (range, 1 month to 12 years). Actuarial survival at 10 years was 98%. Autograft dilation was identified in 31 patients (19%). Regurgitation (>2+) was identified in 12 patients (7%); all 12 had autograft dilation. At 10 years, freedom from autograft dilation was 82%, freedom from autograft dysfunction was 92%, freedom from reoperation on autograft was 92%, and freedom from autograft replacement was 96%. Cox proportional hazard analysis identified preoperative aortic annulus dilation ( z value more than +2.0; p = 0.004), younger age ( p = 0.05), time of surgery (before 2001; p = 0.002), and male sex ( p = 0.01) as predictive of autograft dilation, whereas preoperative ascending aorta diameter ( p = 0.01), male sex ( p = 0.03), and postoperative systemic hypertension ( p = 0.05) were predictive of autograft dysfunction. Conclusions Significant autograft dilation is not common after the Ross procedure. Significant autograft dysfunction affects a minority of patients, but it is more prevalent in those with autograft dilation.</description><identifier>ISSN: 0003-4975</identifier><identifier>EISSN: 1552-6259</identifier><identifier>DOI: 10.1016/j.athoracsur.2006.12.066</identifier><identifier>PMID: 17462399</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Cardiothoracic Surgery ; Child ; Dilatation, Pathologic - epidemiology ; Dilatation, Pathologic - etiology ; Female ; Heart Valve Prosthesis Implantation - adverse effects ; Humans ; Incidence ; Male ; Prevalence ; Pulmonary Artery - pathology ; Pulmonary Artery - transplantation ; Retrospective Studies ; Risk Factors ; Surgery ; Transplantation, Autologous ; Vasodilation</subject><ispartof>The Annals of thoracic surgery, 2007-05, Vol.83 (5), p.1781-1789</ispartof><rights>The Society of Thoracic Surgeons</rights><rights>2007 The Society of Thoracic Surgeons</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c513t-d29138bcb8a944d395bca1e2e1dfa5e2fb9201aea1f87128788f6a7e50a9a2c23</citedby><cites>FETCH-LOGICAL-c513t-d29138bcb8a944d395bca1e2e1dfa5e2fb9201aea1f87128788f6a7e50a9a2c23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17462399$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brown, John W., MD</creatorcontrib><creatorcontrib>Ruzmetov, Mark, MD, PhD</creatorcontrib><creatorcontrib>Rodefeld, Mark D., MD</creatorcontrib><creatorcontrib>Mahomed, Yousuf, MD</creatorcontrib><creatorcontrib>Turrentine, Mark W., MD</creatorcontrib><title>Incidence of and Risk Factors for Pulmonary Autograft Dilation After Ross Aortic Valve Replacement</title><title>The Annals of thoracic surgery</title><addtitle>Ann Thorac Surg</addtitle><description>Background The Ross procedure is an alternative to mechanical aortic valve replacement in the young. Early dilation of the pulmonary autograft root exposed to the systemic circulation has been reported. The aim of our study is to define the prevalence, risk factors, and consequences of autograft dilation. All consecutive adult and pediatric patients who underwent Ross procedure at our institution were retrospectively reviewed for autograft dilation. Methods Between 1993 and 2005, 170 patients (mean age, 24.9 ± 15.5 years; range, 1 month to 61 years) underwent Ross aortic valve replacement: 48% were younger than 19 years old. Eighty-seven additional procedures were performed in 58 patients (34%) at the time of the Ross procedure. End points of the study were freedom from autograft dilation ( z value more than +2.0), autograft dysfunction, autograft reoperation, and autograft replacement. Results There were 2 early and 1 late deaths during a mean follow-up of 5.1 ± 3.0 years (range, 1 month to 12 years). Actuarial survival at 10 years was 98%. Autograft dilation was identified in 31 patients (19%). Regurgitation (>2+) was identified in 12 patients (7%); all 12 had autograft dilation. At 10 years, freedom from autograft dilation was 82%, freedom from autograft dysfunction was 92%, freedom from reoperation on autograft was 92%, and freedom from autograft replacement was 96%. Cox proportional hazard analysis identified preoperative aortic annulus dilation ( z value more than +2.0; p = 0.004), younger age ( p = 0.05), time of surgery (before 2001; p = 0.002), and male sex ( p = 0.01) as predictive of autograft dilation, whereas preoperative ascending aorta diameter ( p = 0.01), male sex ( p = 0.03), and postoperative systemic hypertension ( p = 0.05) were predictive of autograft dysfunction. Conclusions Significant autograft dilation is not common after the Ross procedure. Significant autograft dysfunction affects a minority of patients, but it is more prevalent in those with autograft dilation.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Cardiothoracic Surgery</subject><subject>Child</subject><subject>Dilatation, Pathologic - epidemiology</subject><subject>Dilatation, Pathologic - etiology</subject><subject>Female</subject><subject>Heart Valve Prosthesis Implantation - adverse effects</subject><subject>Humans</subject><subject>Incidence</subject><subject>Male</subject><subject>Prevalence</subject><subject>Pulmonary Artery - pathology</subject><subject>Pulmonary Artery - transplantation</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Surgery</subject><subject>Transplantation, Autologous</subject><subject>Vasodilation</subject><issn>0003-4975</issn><issn>1552-6259</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1v1DAQhi1ERZfSv4B84pbgj3z5grQUCpUqFS3QqzVxxuBtEi-2U6n_Hke7UiVOnEbWvO-M53kJoZyVnPHm_b6E9NsHMHEJpWCsKbkoWdO8IBte16JoRK1ekg1jTBaVautz8jrGfX6K3H5FznlbNUIqtSH9zWzcgLNB6i2FeaA7Fx_oNZjkQ6TWB_ptGSc_Q3ii2yX5XwFsop_cCMn5mW5twkB3Pka69SE5Q-9hfES6w8MIBiec0xtyZmGMeHmqF-Tn9ecfV1-L27svN1fb28LUXKZiEIrLrjd9B6qqBqnq3gBHgXywUKOwvRKMAwK3XctF13adbaDFmoECYYS8IO-Ocw_B_1kwJj25aHAcYUa_RN2ySgolWRZ2R6EJ-d8BrT4EN-UDNWd65av3-pmvXvlqLnTmm61vTzuWfsLh2XgCmgUfjwLMlz46DDoat-IdXECT9ODd_2z58M8QM7rZGRgf8Anj3i9hziQ11zEb9Pc15zVm1q4RMyn_AjOKp0A</recordid><startdate>20070501</startdate><enddate>20070501</enddate><creator>Brown, John W., MD</creator><creator>Ruzmetov, Mark, MD, PhD</creator><creator>Rodefeld, Mark D., MD</creator><creator>Mahomed, Yousuf, MD</creator><creator>Turrentine, Mark W., MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070501</creationdate><title>Incidence of and Risk Factors for Pulmonary Autograft Dilation After Ross Aortic Valve Replacement</title><author>Brown, John W., MD ; Ruzmetov, Mark, MD, PhD ; Rodefeld, Mark D., MD ; Mahomed, Yousuf, MD ; Turrentine, Mark W., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c513t-d29138bcb8a944d395bca1e2e1dfa5e2fb9201aea1f87128788f6a7e50a9a2c23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Cardiothoracic Surgery</topic><topic>Child</topic><topic>Dilatation, Pathologic - epidemiology</topic><topic>Dilatation, Pathologic - etiology</topic><topic>Female</topic><topic>Heart Valve Prosthesis Implantation - adverse effects</topic><topic>Humans</topic><topic>Incidence</topic><topic>Male</topic><topic>Prevalence</topic><topic>Pulmonary Artery - pathology</topic><topic>Pulmonary Artery - transplantation</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Surgery</topic><topic>Transplantation, Autologous</topic><topic>Vasodilation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brown, John W., MD</creatorcontrib><creatorcontrib>Ruzmetov, Mark, MD, PhD</creatorcontrib><creatorcontrib>Rodefeld, Mark D., MD</creatorcontrib><creatorcontrib>Mahomed, Yousuf, MD</creatorcontrib><creatorcontrib>Turrentine, Mark W., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Annals of thoracic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brown, John W., MD</au><au>Ruzmetov, Mark, MD, PhD</au><au>Rodefeld, Mark D., MD</au><au>Mahomed, Yousuf, MD</au><au>Turrentine, Mark W., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incidence of and Risk Factors for Pulmonary Autograft Dilation After Ross Aortic Valve Replacement</atitle><jtitle>The Annals of thoracic surgery</jtitle><addtitle>Ann Thorac Surg</addtitle><date>2007-05-01</date><risdate>2007</risdate><volume>83</volume><issue>5</issue><spage>1781</spage><epage>1789</epage><pages>1781-1789</pages><issn>0003-4975</issn><eissn>1552-6259</eissn><abstract>Background The Ross procedure is an alternative to mechanical aortic valve replacement in the young. Early dilation of the pulmonary autograft root exposed to the systemic circulation has been reported. The aim of our study is to define the prevalence, risk factors, and consequences of autograft dilation. All consecutive adult and pediatric patients who underwent Ross procedure at our institution were retrospectively reviewed for autograft dilation. Methods Between 1993 and 2005, 170 patients (mean age, 24.9 ± 15.5 years; range, 1 month to 61 years) underwent Ross aortic valve replacement: 48% were younger than 19 years old. Eighty-seven additional procedures were performed in 58 patients (34%) at the time of the Ross procedure. End points of the study were freedom from autograft dilation ( z value more than +2.0), autograft dysfunction, autograft reoperation, and autograft replacement. Results There were 2 early and 1 late deaths during a mean follow-up of 5.1 ± 3.0 years (range, 1 month to 12 years). Actuarial survival at 10 years was 98%. Autograft dilation was identified in 31 patients (19%). Regurgitation (>2+) was identified in 12 patients (7%); all 12 had autograft dilation. At 10 years, freedom from autograft dilation was 82%, freedom from autograft dysfunction was 92%, freedom from reoperation on autograft was 92%, and freedom from autograft replacement was 96%. Cox proportional hazard analysis identified preoperative aortic annulus dilation ( z value more than +2.0; p = 0.004), younger age ( p = 0.05), time of surgery (before 2001; p = 0.002), and male sex ( p = 0.01) as predictive of autograft dilation, whereas preoperative ascending aorta diameter ( p = 0.01), male sex ( p = 0.03), and postoperative systemic hypertension ( p = 0.05) were predictive of autograft dysfunction. Conclusions Significant autograft dilation is not common after the Ross procedure. Significant autograft dysfunction affects a minority of patients, but it is more prevalent in those with autograft dilation.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>17462399</pmid><doi>10.1016/j.athoracsur.2006.12.066</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-4975 |
ispartof | The Annals of thoracic surgery, 2007-05, Vol.83 (5), p.1781-1789 |
issn | 0003-4975 1552-6259 |
language | eng |
recordid | cdi_proquest_miscellaneous_70432930 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Adolescent Adult Cardiothoracic Surgery Child Dilatation, Pathologic - epidemiology Dilatation, Pathologic - etiology Female Heart Valve Prosthesis Implantation - adverse effects Humans Incidence Male Prevalence Pulmonary Artery - pathology Pulmonary Artery - transplantation Retrospective Studies Risk Factors Surgery Transplantation, Autologous Vasodilation |
title | Incidence of and Risk Factors for Pulmonary Autograft Dilation After Ross Aortic Valve Replacement |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T14%3A34%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incidence%20of%20and%20Risk%20Factors%20for%20Pulmonary%20Autograft%20Dilation%20After%20Ross%20Aortic%20Valve%20Replacement&rft.jtitle=The%20Annals%20of%20thoracic%20surgery&rft.au=Brown,%20John%20W.,%20MD&rft.date=2007-05-01&rft.volume=83&rft.issue=5&rft.spage=1781&rft.epage=1789&rft.pages=1781-1789&rft.issn=0003-4975&rft.eissn=1552-6259&rft_id=info:doi/10.1016/j.athoracsur.2006.12.066&rft_dat=%3Cproquest_cross%3E70432930%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70432930&rft_id=info:pmid/17462399&rft_els_id=S0003497507000203&rfr_iscdi=true |